Page last updated: 2024-11-02

pirenzepine and Injuries, Spinal Cord

pirenzepine has been researched along with Injuries, Spinal Cord in 2 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Somogyi, GT1
Zernova, GV1
Yoshiyama, M1
Rocha, JN1
Smith, CP1
de Groat, WC1
Sigman, HH1
Poleski, MH1
Gillich, A1

Other Studies

2 other studies available for pirenzepine and Injuries, Spinal Cord

ArticleYear
Change in muscarinic modulation of transmitter release in the rat urinary bladder after spinal cord injury.
    Neurochemistry international, 2003, Volume: 43, Issue:1

    Topics: Animals; Atropine; Electric Stimulation; Female; Muscarinic Antagonists; Neurotransmitter Agents; Pi

2003
Effects of pirenzepine on acute mucosal erosions, gastric acid and mucosal blood flow in the spinal rat stomach.
    Digestion, 1991, Volume: 49, Issue:4

    Topics: Animals; Antacids; Gastric Acid; Gastric Mucosa; Male; Pirenzepine; Rats; Rats, Inbred Strains; Regi

1991